bg
bg

Janis Oklis

The Subscription Paradox: How Apple is Formalizing the Twelve-Month Handcuff
Soft and Apps

Apple introduces monthly-billed 12-month subscriptions. A deep dive into how this formalizes discounts and shifts the economics of the App Store.

Janis Oklis
Janis Oklis
April 29, 2026
The Anatomy of a Market Recovery: Why Even Decentralized Dreams Now Depend on the Fed
Crypto Currency

Bitcoin sees record $1B+ weekly inflows, but the Fed's next move holds the key. Discover why institutional demand and macro policy are now inseparable.

Janis Oklis
Janis Oklis
April 28, 2026
The Quiet Fragmentation of the Everything App
Soft and Apps

XChat launches on iOS, signaling a shift from X's "Everything App" vision to a fragmented xAI app suite. We explore the UX and security implications.

Janis Oklis
Janis Oklis
April 27, 2026
Your AI Is Learning to Shop, Negotiate, and Outsmart You
Tech and Innovation

Anthropic's Project Deal shows AI agents negotiating real deals with real money. Discover how 'agent-on-agent' commerce will change how you shop and save.

Janis Oklis
Janis Oklis
April 26, 2026
Google’s Internal AI Divide Proves Even the Giants Can’t Force Their Own Employees to Use Their Software
Industry News

Google's internal divide over Claude vs. Gemini reveals a high-stakes battle for AI productivity. See why even Google engineers prefer the competition.

Janis Oklis
Janis Oklis
April 22, 2026
Can an App Really Save You from Your Smartphone?
Industry News

Bond is a new AI-powered social platform designed to end doomscrolling by suggesting real-world activities based on your digital memories.

Janis Oklis
Janis Oklis
April 21, 2026
Forget the Chatbots—The Real AI Fortune Is in Renting Out the Hardware
Industry News

Elon Musk's xAI is renting out massive GPU power to the $29B coding startup Cursor. Explore what this cloud pivot means for the future of everyday apps.

Janis Oklis
Janis Oklis
April 19, 2026
Why OpenAI’s New Drug-Hunting AI Is a Breakthrough You Can’t Touch
Artificial Intelligence

OpenAI unveils GPT-Rosalind, a specialized AI for drug discovery. Learn how this restricted model could shave years off medical research and why you can't use it.

Janis Oklis
Janis Oklis
April 18, 2026
bg
bg
bg

Join us and become one of thousands utilizing our secured platform on daily basis.

Our end-to-end encrypted email and cloud storage solution provides most powerful means of secure communication, ensuring the safety and privacy of your data.

/ Create free account